AIRA Matrix collaborates with Muljibhai Patel Urological Hospital and Gujarat Imaging Centre
To develop AI-based solutions for prostate cancer care
AIRA Matrix announced a collaboration with Muljibhai Patel Urological Hospital, Nadiad (MPUH), a urology institute, and Gujarat Imaging Centre, Ahmedabad (GIC), a pioneer diagnostic centre for radiology services.
The collaboration will enable the development of AI-based solutions that provide insights from radiology and histopathology data for accurate risk stratification and therapy institutions in prostate cancer.
As part of this collaboration, MPUH and GIC will provide domain expertise in uro-oncology, histopathology and radiology and work with the AIRA Matrix team to enable the development of a Deep Learning- based solution that augments multi-parametric MRI (mpMRI) and histopathology reporting.
Chaith Kondragunta, CEO, AIRA Matrix said, “Our goal is to use our technological expertise to improve screening, prognostication, therapy planning and follow up of prostate cancers – with better outcomes for the patient as well as the caregivers. We are pleased and honoured to be working with leading experts in this area from MPUH and GIC and are excited about the possibilities of improving the prostate cancer care pathway via this collaboration.”
Dr Hemant Patel, Director, GIC and Past President of Indian Radiology Imaging Association (IRIA) added, “We at GIC strive to remain updated, bringing the latest available technology in the field of radiology and continue to collaborate with newer avenues to enhance patient care and carve a path for better diagnostic solutions in future. Such collaborations can further bridge the gap between imaging and final histo-pathological diagnosis.”
Dr Drushi Patel, Consultant Radiologist, Gujarat imaging Centre (GIC), an expert on Prostate MRI reporting stated, “Prostate MR imaging has evolved to be an acceptable noninvasive imaging tool to guide management decisions and biopsy planning for prostate cancer. We, at GIC have been involved with providing the latest diagnostic solutions in Onco imaging and share a wealth of experience for Prostate MR imaging in particular, as it has evolved to its present role in clinical practice.”
